Percepta® GSC - Hear from Peers

HEAR FROM PEERS

Peer-to-peer learning hub

Play Video

Novel Genomic Testing: Improving Diagnostic Confidence for Lung Nodules

Hear how Dr. Kurman uses Percepta GSC to stratify the risk of primary lung cancer across all pre-test risk groups to guide patient management when bronchoscopy is inconclusive

Case Studies & Presentations

Percepta GSC resource library

Watch case studies and testimonials from physicians or on-demand videos about Percepta GSC and its clinical utility.

Percepta GSC and Envisia Classifier  Case Study

Dr. Nina Maouelainin shares a case where Percepta GSC up-classified the risk of lung cancer guiding the next intervention step, and Envisia determined a UIP pattern to improve ILD diagnostic confidence, guiding management using a non-invasive bronchoscopy.

Percepta GSC Up-Classification Case Study

Dr. Andres Yepes shares a clinical case where Percepta GSC up-classified the risk of lung cancer for an intermediate pre-test risk patient with an inconclusive bronchoscopy, informing the next intervention steps.

Percepta GSC Down-Classification  Case Study

Dr. Andres Yepes shares a case where Percepta GSC down-classified the risk of lung cancer for an intermediate pre-test risk patient with an inconclusive bronchoscopy, saving the patient from an unnecessary invasive procedure.

Percepta GSC Physician Testimonial

Hear from Dr. Nina Maouelainin on how she integrated Percepta GSC into her clinical practice and the test’s impact on patient management.

Percepta GSC Clinical Case Review

Dr. Krish Bhadra shares a case where Percepta GSC down-classified the risk and changed patient management.

Novel Genomic Testing: Improving Diagnostic Confidence for Lung Nodules

Hear how Dr. Kurman uses Percepta GSC to stratify the risk of primary lung cancer across all pre-test risk groups as a guide for patient management when bronchoscopy is inconclusive.

Percepta GSC Overview and Integration in Clinical Practice

Dr. Chakravarthy Reddy, Associate Professor, University of Utah School of Medicine, shares an overview of the Percepta Genomic Sequencing Classifier to stratify the risk of lung cancer when bronchoscopy is inconclusive and how to integrate this test into clinical practice.

ASCO 2021 Percepta GSC

In this research, Dr. Sonali Sethi and colleagues assess the potential clinical utility of the Percepta Genomic Sequencing Classifier (GSC) in up-classifying pre-test high risk lung nodules to very high risk (>91%) after a nondiagnostic bronchoscopy.

Stratify the risk of primary lung cancer to guide patient management

Inconclusive bronchoscopy results can lead to uncertainty in next steps and delays in diagnosis. Percepta GSC stratifies the risk of primary lung cancer to guide patient management when bronchoscopy is inconclusive.

How can we help?

Veracyte representatives are happy to assist you and to discuss how to integrate our tests into your practice. Monday-Friday, 5:30AM - 5PM (Pacific Time)

Headquarters

6000 Shoreline Court, Suite 300
South San Francisco, CA 94080

Client services

+1.844.464.5864 Office
+1.650.243.6335 Fax

Support email

support@veracyte.com

The Percepta Genomic Sequencing Classifier (GSC) is available in the US as part of Veracyte’s CLIA-validated laboratory developed test (LDT) service. This test has not been cleared or approved by the FDA.

This website contains information on products that are targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for you accessing such information that may not comply with any legal process, regulation, registration or usage in the country of your origin.

© 2023 Veracyte, Inc. All rights reserved.

Offices

6000 Shoreline Court, Suite 300  
South San Francisco, CA 94080

163 Avenue de Luminy
13009 Marseille
FRANCE

6925 Lusk Boulevard, Suite 200
San Diego, CA 92121

12357-A Riata Trace Parkway
Building 5, Suite 100
 Austin, TX 78727

Helpful links

Cookie Settings

Connect